✦ LIBER ✦

A multicenter, randomized phase III study of docetaxel + cisplatin (DC) vs docetaxel + carboplatin (DCb) vs vinorelbine + cisplatin (VC) in chemotherapy-naive patients (Pts) with advanced and metastatic non-small cell lung cancer (NSCLC)

✍ Scribed by Belani, C.P; Rodriguez, J; von Pawel, J; Pluzanska, A; Gorbounova, V; Millward, M; Bosquée, L; Kim, Y; Gamza, F; Berille, J; Hammershaimb, L; Fossella, F

Book ID: 118569740
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 98 KB
Volume: 29
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(00)80195-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel + Cisplatin (DC) and Docetaxel

Docetaxel + Cisplatin (DC) and Docetaxel + Carboplatin (DCb) vs Vinorelbine + Cisplatin (VC) in chemotherapy-naïve patients with advanced and metastatic non-small cell lung cancer (NSCLC): Results of a multicenter, randomized phase III study

✍ F. Fossella 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 140 KB

776 An economic analysis of the TAX 326

776 An economic analysis of the TAX 326 trial: a multicenter randomized study of docetaxel + cisplatin (DC) or docetaxel + carboplatin (DCb) vs. vinorelbine + cisplatin (VC) as first-line therapy in advanced non-small cell lung cancer (NSCLC)

✍ N. Leighl; F.A. Shepherd; W.S. Tsao; P. Lindgren; C.B. Belani; F.V. Fossella; P. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 336 KB

P-452 Phase III study of docetaxel-cispl

P-452 Phase III study of docetaxel-cisplatin (DC) or docetaxel-carboplatin (DCb) versus vinorelbine-cisplatin (VC) as first-line treatment of advanced non-small cell lung cancer (NSCLC): Analyses by gender

✍ Belani, C.; von Pawel, J.; Pluzanska, A.; Gorbounova, V.; Kaukel, E.; Mattson, K 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 145 KB

O-51 Phase III study (TAX 326) of doceta

O-51 Phase III study (TAX 326) of docetaxel-cisplatin (DC) and docetaxel-carboplatin (DCB) versus vinorelbine-cisplatin (VC) for the first-line treatment of advanced/metastatic non-small cell lung cancer (NSCLC): analyses in elderly patients

✍ Belani, Chandra P.; Fossella, Frank V. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Cisplatin-vindesine-mitomycin (MVP) vs c

Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study

✍ Baldini, E; Tibaldi, C; Ardizzoni, A; Salvati, F; Antilli, A; Portalone, L; Barb 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 683 KB

Docetaxel Versus Docetaxel/Cisplatin in

Docetaxel Versus Docetaxel/Cisplatin in Patients with Advanced Non–Small-Cell Lung Cancer: Preliminary Analysis of a Multicenter, Randomized Phase III Study

✍ V. Georgoulias; A.G. Pallis; C. Kourousis; A. Alexopoulos; A. Ardavanis; A. Agel 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 150 KB